HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
HYFT
MindWalk Holdings Corp.
HYFT lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
HYFT Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Strong |
HYFT's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
HYFT PE Valuation
HYFT has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
HIMS has the edge over HYFT on the outlook, with more favorable profitability expectations.
HYFT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Growth | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect HYFT's losses to grow, with revenue growing.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HYFT has the stronger earnings trend. Trailing diluted EPS is down 257% for HIMS versus HYFT down 135%.
HYFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2022 | -$0.75 | -$0.34 |
| Q2 2022 | -$0.60 | -$0.29 |
| Q1 2022 | -$0.65 | -$0.50 |
| Q4 2021 | -$0.57 | -$0.44 |
| Q3 2021 | -$0.41 | -$0.23 |
| Q2 2021 | -$0.31 | -$0.05 |
| Q1 2021 | -$0.15 | +$0.26 |
| Q4 2020 | -$0.13 | +$0.31 |
HYFT is still losing money, but far less than before: $0.26 per share over the past year, against $0.75 at its worst in mid-2022.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over HYFT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over HYFT on profitability, with a higher operating margin.
HYFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.7M | +23% |
| Q2 2026 | $2.9M | -42% |
| Q1 2026 | $2.9M | -32% |
| Q4 2025 | $2.9M | -33% |
| Q3 2025 | $2.2M | -40% |
| Q2 2025 | $4.9M | +8.1% |
| Q1 2025 | $4.3M | -1.1% |
| Q4 2024 | $4.3M | -0.4% |
HYFT's revenue is recovering but still below its 2025 peak: $3M last quarter, up 23% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -160% | -28 points |
| Q2 2026 | -105% | -78 points |
| Q1 2026 | -95% | +304 points |
| Q4 2025 | -77% | -28 points |
| Q3 2025 | -132% | -42 points |
| Q2 2025 | -27% | +264 points |
| Q1 2025 | -399% | -343 points |
| Q4 2024 | -50% | -16 points |
HYFT's operating margin was −160% last quarter, down 28 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over HYFT on cash generation, producing positive trailing cash flow while its opponent burns cash.
HYFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.9M | +$218.3K |
| Q2 2026 | -$1.8M | -$719.4K |
| Q1 2026 | -$2.1M | -$1.2M |
| Q4 2025 | -$2.1M | -$447.1K |
| Q3 2025 | -$3.2M | -$1.7M |
| Q2 2025 | -$1.1M | +$1.6M |
| Q1 2025 | -$924.5K | -$572.3K |
| Q4 2024 | -$1.6M | -$1.4M |
HYFT has burned cash in almost every quarter: −$9M over the past year, against −$7M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over HYFT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
HYFT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +95.2K shares |
| 1 year | +1.4% | +653K shares |
| 3 years | +87% | +21.8M shares |
| 5 years | +177% | +29.9M shares |
| Available history | +244% | +33.2M shares |
HYFT has 47M diluted shares, up 1.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
HYFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2021 | -7.4x | Net Cash |
| Q4 2020 | -5.5x | Net Cash |
| Q3 2020 | -0.8x | Net Cash |
HYFT has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
HYFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.9 | Neutral |
| Stochastic | 8.2 | Oversold |
HYFT's weekly RSI is 36 (neutral) and its Stochastic is 8 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
HYFT PE vs Healthcare Sector
HYFT has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
HYFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.23 | 19% below |
| 20 week MA | $1.32 | 24% below |
| 50 week MA | $1.45 | 31% below |
| 100 week MA | $1.28 | 22% below |
| 200 week MA | $1.56 | 36% below |
HYFT is in a downtrend: it's below all five of its weekly moving averages, and 36% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
HYFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.20 | $16.4 | +645% |
| 2021 | $16.4 | $5.36 | -67% |
| 2022 | $5.36 | $5.72 | +6.7% |
| 2023 | $5.72 | $1.71 | -70% |
| 2024 | $1.71 | $0.41 | -76% |
| 2025 | $0.41 | $1.70 | +315% |
| 2026 YTD | $1.70 | $1.00 | -41% |
HYFT has the edge over HIMS on returns for 2026, with the stronger performance.